Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE recommends new life-extending treatment for rare form of gastroesophageal cancer

November 25, 2022
Medical Communications

Clinical evidence shows Bristol Myers Squibb’s nivolumab, with chemotherapy, could help extend the lives of patients with untreated HER2-negative, advanced …

News

The University of Bristol trial to test rapid checks for reduction of antibiotic prescriptions

November 24, 2022
Business Services

The University of Bristol has begun a trial to see if the rapid testing of initial symptoms could cut the number …

News

Iveda reveals AI-driven caregiver assistant, IvedaCare

November 24, 2022
Business Services

Iveda, a US-based technology company, has introduced their new cloud-based artificial intelligence (AI) assistant called IvedaCare. The company says they …

News
dr-frank-mathias

Dr Frank Mathias

November 23, 2022

Dr Frank Mathias has been appointed as life science firm Oxford Biomedica’s new CEO. Dr Mathias will take on his …

Appointment

Novo Nordisk suffers profit loss over obesity drug as manufacturing problems continue

November 23, 2022
Sales and Marketing

Danish pharma company Novo Nordisk, has reported a 2% loss in their third quarter sales report, compared to the previous …

News

Lunit first SaMD in APAC region to secure CE mark and UKCA certification for AI-based radiology solution

November 23, 2022
Research and Development

Lunit, a South Korean medical software company, has become the first software as a medical device (SaMD) company in the …

News

Haemophilia drug costing $3.5m per dose has been approved

November 23, 2022
Sales and Marketing

CSL Behring’s haemophilia B gene therapy has recently been approved by US regulators, however the treatment has an enormous price …

News

SMC accepts HRT treatment Bijuve for use across NHS Scotland

September 13, 2022
Manufacturing and Production

The SMC has accepted HRT treatment, Bijuve, for use across NHS Scotland. Bijuve is the first and only body-identical HRT …

News

New malaria vaccine demonstrates high efficacy

September 9, 2022
Medical Communications

  A new malaria vaccine could be pivotal in the fight against the deadly disease. This vaccine has been developed …

News

Self-sterilising plastic kills viruses such as COVID-19

September 9, 2022
Medical Communications

Scientists from Queen’s University Belfast have developed a virus-killing plastic that could make it harder for bugs, such as COVID-19, …

News

Brainomix and Bridge Biotherapeutics enter artificial intelligence partnership

September 8, 2022
Business Services

Brainomix – the AI-powered MedTech solutions company – and Bridge Biotherapeutics, a clinical-stage biotechnology company focused on developing novel drugs …

News

UCB reveals new Bimzelx ‘complete skin clearance’ data

September 8, 2022
Business Services

UCB has announced new three-year results from the BE BRIGHT open-label extension study evaluating the long-term safety, tolerability and efficacy …

News

BioInnovation Institute reveals new cohort entering Venture Lab programme

September 7, 2022
Research and Development

 The group consists of nine ventures plus two corporate-sponsored innovation projects from Novo Nordisk – all aligned with BII’s focus …

News

Tomato flu outbreak in India

August 25, 2022
Business Services

An outbreak of a viral infection known as “tomato flu” has led to India’s government issuing an advisory to all …

News

Number of COVID-19 patients in Scotland’s hospitals drops by 12 percent

August 25, 2022
Business Services

The number of COVID-19 patients in Scotland’s hospitals has fallen by over 12 percent, as shown by the latest weekly …

News

COVID-19 testing paused in NHS and care homes

August 25, 2022
Business Services

The UK government has shared that most hospital patients and care home residents in England will no longer be tested …

News

New study reveals the range of co-morbidities faced by patients with type 2 diabetes

August 24, 2022
Research and Development

A new study has revealed the range and type of illnesses that people with type 2 diabetes are living with, …

News

Oxford Uni scientists study Siga’s Tpoxx for protection against monkeypox

August 24, 2022
Research and Development

The team at Oxford University, who conducted the landmark RECOVERY trial of COVID-19 therapies, is now studying if Siga Technologies’ …

News

Paediatric Investigation Plan approved by MHRA

August 24, 2022
Research and Development

Northwest Biotherapeutics has announced the approval from the MHRA of the company’s Paediatric Investigation Plan (PIP). The development, regulatory review, …

News

Togo becomes first country to eliminate four neglected tropical diseases

August 24, 2022
Research and Development

WHO has announced that the Republic of Togo has been confirmed as the first country to eliminate four devastating neglected …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025